Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Arizona State University (ASU) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SleepWell24 Smart Application | Experimental | This group will consists of participates who will be on study for 8 weeks using the Sleepwell24 application. Once 20 people are enrolled on the 8 week cohort, a 6 month cohort will open up for 20 different participants. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SleepWell24 Application | Behavioral | The SleepWell24 application will use connections with a Shelly smart plug and a Fitbit Charge 4 along with weekly questionnaires to monitor CPAP usage. |
| Measure | Description | Time Frame |
|---|---|---|
| CPAP Adoption | The Shelly smart plug will be used to monitor the amount of CPAP time usage by the amount of wattage recorded. | approximately 6 months |
| Change in Quality of Life | As measured by weekly survey asking participants to rate their health based on excellent, very good, good, fair, and poor. | baseline, weekly assessments for approximately 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in sleep time | As measured by the Fitbit Charge 4 sensor, reported in hours | baseline, weekly assessments for approximately 6 months |
| Change in physical activity | As measured by the Fitbit Charge 4 sensor step count, reported as number of steps taken daily |
Not provided
Inclusion Criteria:
In both trials of Aim 2, twenty adults (≥18 years) per trial will be recruited who are newly diagnosed with OSA and speak English.
In both trials, we will purposely recruit samples balanced by biological sex and OSA severity (apnea hypopnea index: 5-14 vs. ≥ 15).
Inclusion Criteria are the same for both Aim 2 trials; Adult patients from MCCSM sites who:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Timothy Morgenthaler, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Arizona | Recruiting | Scottsdale | Arizona | 85259 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020181 | Sleep Apnea, Obstructive |
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline, weekly assessments for approximately 6 months |
| Change in sedentary time | As measured by the Fitbit Charge 4 sensor, reported in hours | baseline, weekly assessments for approximately 6 months |
| Mayo Clinic in Rochester | Recruiting | Rochester | Minnesota | 55905 | United States |
|
| D020919 |
| Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |